Dr. Stoler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1215 Lee St
Charlottesville, VA 22908Phone+1 888-882-3990Fax+1 434-243-6499
Education & Training
- University of RochesterResidency, Pathology-Anatomic and Clinical, 1980 - 1985
- Rochester General HospitalResidency, Internal Medicine, 1980 - 1980
- University of Rochester School of Medicine and DentistryClass of 1980
- University of RochesterFellowship, Cytopathology
Certifications & Licensure
- OH State Medical License 1989 - 2026
- TN State Medical License 2021 - 2026
- VA State Medical License 1993 - 2026
- MS State Medical License 2021 - 2025
- NY State Medical License 1981 - 2025
- WV State Medical License 2015 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 28 citationsHypophyseal metastatic renal cell carcinoma and pituitary adenoma: Case report and review of the literatureRay L. James, Gregory Arsenis, Mark H. Stoler, Curtis N. Nelson, Daniel T. Baran
The American Journal of Medicine. 1984-02-01 - 32 citationsIn situ hybridization.Mark H. Stoler
Clinics in Laboratory Medicine. 1990-03-01 - 66 citationsInterlaboratory variation in the performance of liquid‐based cytology: Insights from the ATHENA trialThomas C. Wright, Mark H. Stoler, Catherine M. Behrens, Abha Sharma, Keerti Sharma
International Journal of Cancer. 2014-04-15
Journal Articles
- HPV RNA in Situ Hybridization Can Inform Cervical Cytology‐Histology CorrelationJoseph D Coppock, Mark H Stoler, Anne M Mills, Cancer Cytopathology
Press Mentions
- Abbott Receives FDA Approval for HPV Test to Run on Alinity M, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPVNovember 3rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: